Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135856) titled 'Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC' on Aug. 8.
Study Type: Observational
Primary Sponsor: Shanghai Chest Hospital
Condition:
Lung Cancer
Neoadjuvant Therapy
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2025
Target Sample Size: 400
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07135856
Published by HT Digital Content Services with permission from Health Daily Digest....